Piperazine ethylamide derivatives with 5-ht1a receptor activity

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 295/13 (2006.01) A61K 31/495 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2351860

Compounds of formula (I) are useful for the treatment of disorder of the central nervous system including anxiety, depression, panic, alcohol and drug addiction, sexual dysfunction, sleep disorders, migraine, obesity, cognitive disorders, and neurodegenerative diseases.

La présente invention concerne des composés de formule (I) qui sont utiles dans le traitement de troubles du système nerveux central, y compris l'anxiété, la dépression, la panique, l'alcoolisme et la toxicomanie, les dysfonctionnements sexuels, les troubles du sommeil, la migraine, l'obésité, les troubles cognitifs, et les maladies neurodégénératives.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperazine ethylamide derivatives with 5-ht1a receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine ethylamide derivatives with 5-ht1a receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine ethylamide derivatives with 5-ht1a receptor activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1427580

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.